Addex ADX48621 Positive Primate Parkinson's Data
ADX48621 shows efficacy on both chorea and dystonia in PD-LID model
24-Nov-2009 -
Addex Pharmaceuticals announced that in a non-human primate model of Parkinson's disease (PD) levodopa induced dyskinesia (LID), ADX48621 statistically and significantly inhibited LID. More specifically, the compound inhibited dose dependently both chorea and dystonia, the two major components of ...
gastroesophageal reflux disease
levodopa induced dyskinesia
migraine
+2